Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine Feb/03/2022 60 0
S2K146 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/06/2022 2 0
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine Jan/04/2022 16 1
Convalescent plasma Emergency use authorization Experimental Antiviral Jan/04/2022 40 10
Mesenchymal stem cells Potential treatment - clinical evidence Experimental Other treatment Dec/24/2021 48 0
S2X259 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021 2 0
LSNME/SW1 Potential treatment - pre-clinical evidence Experimental Vaccine Oct/01/2021 2 0
Interferon beta Potential treatment - theoretical effect Used to treat other disease Antiviral May/12/2021 3 1
Interferon alfa Recommended by China's NHC Guidelines Used to treat other disease Antiviral May/12/2021 6 1
aly-miR396a-5p Potential treatment - pre-clinical evidence Natural product Antiviral May/10/2021 1 0